Research Award: Patients Informing Practice

Earlier this Fall at Medicine 2.0, PatientsLikeMe was honored to receive the inaugural Journal of Medical Internet Research (JMIR) Award for our paper on what we can learn about drugs post market from patients reporting treatment experiences on PatientsLikeMe.

Once a drug is on the market, it can be difficult to evaluate how it’s working in the real world for different kinds of people using it for different purposes. In this paper, our research team examined how we can learn from collecting the experiences from individual members scattered around the world into a single database. The study focused on Amitriptyline, a medication used widely and for a variety of purposes, and reports on why patients take it, the efficacy of the drug, its side-effects and associated burden.

To see patients’ real world experiences with a specific treatment, like Amitriptyline, you can browse the thousands of treatment reports shared on PatientsLikeMe.  You can also view a summary of our Medicine 2.0 presentation here or below to learn more about this study.  The full paper will be published in 2010, so stay tuned!

PatientsLikeMe member jfrost

1 Comment »

  1. [...] continued their analysis of the real-world data being shared by patients like you.  Awarded the inaugural JMIR award at Medicine 2.0, the PatientsLikeMe research team published pieces on compulsive gambling in [...]

    Pingback by The Value of Openness: The PatientsLikeMe Blog » A Year in Review: PatientsLikeMe in 2009 — December 31, 2009 @ 2:14 pm

RSS feed for comments on this post. TrackBack URL

Leave a comment

NOTE: You’ve got something to say and we want to hear it. If you’d like your comment to be displayed here, please follow these guidelines:

  1. Be nice. Expressing your opinion is encouraged, but rude, inflammatory or inappropriate comments are not allowed.
  2. Add value. Submit comments that are clear and stay on topic.
  3. Be patient. We publish comments a few times per week.
  4. Know where you are. This is an open blog that everyone on the Internet can read. Your comments may be repurposed and used elsewhere (e.g., Twitter, Facebook, etc.).

Thanks again for sharing your insights and opinions with us and our readers!